ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer https://www.biorxiv.org/content/10.1101/2023.04.03.535346v1?med=mas
ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer https://www.biorxiv.org/content/10.1101/2023.04.03.535346v1?med=mas